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Department of Immunology, IMM-8, Research Institute of Scripps Clinic, La Jolla, California 92037; and * Department of Physiology, 
Division of Neuroscience and Howard Hughes Medical Institute, University of California, San Francisco, California 94143-0724 
Abstract. The integrin ~6/34 is a heterodimer predomi- 
nantly expressed by epithelia. While no definite recep- 
tor function has yet been assigned to it, this integrin 
may mediate adhesive and/or migratory functions of 
epithelial cells. We have determined the complete pri- 
mary structure of both the as and/34 subunits from 
cDNA clones isolated from pancreatic arcinoma cell 
line libraries. The deduced amino acid sequence of or6 
is homologous to other integrin o~ chains (18-26% 
identity). Antibodies to an a6 carboxy terminus pep- 
tide immunoprecipitated 0t6~4 complexes from carci- 
noma cells and 0t6/31 complexes from platelets, provid- 
ing further evidence for the association of ~6 with 
more than one t3 subunit. The deduced amino acid se- 
quence of/34 predicts an extracellular portion homolo- 
gous to other integrin/3 chains, and a unique cyto- 
plasmic domain comprised of > 1,000 residues. This 
agrees with the structures of the ~4 cDNAs from nor- 
mal epithelial cells (Suzuki, S., and Y. Naitoh. 1990. 
EMBO [Eur. Mol. Biol. Organ.] J. 9:757-763; Hoger- 
vost, E, I. Kuikman, A. E. G. Kr. von dem Borne, 
and A. Sonnenberg. 1990. EMBO [Eur. Mol. Biol. 
Organ.] J. 9:765-770). Compared to these structures, 
however, the /~4 cDNAs that we have cloned from car- 
cinoma cells contain extra sequences. One of these is 
located in the 5'-untranslated region, and may encode 
regulatory sequences. Another specifies a segment of 
70 amino acids in the cytoplasmic tail. Amplification 
by reverse transcription-polymerase chain reaction of 
mRNA indicated that multiple forms of ~4 may exist, 
possibly due to cell-type specific alternative splicing. 
The unique structure of/34 suggests its involvement in 
novel cytoskeletal interactions. Consistent with this 
possibility, 0t6~4 is mostly concentrated on the basal 
surface of epithelial cells, but does not colocalize with 
components of adhesion plaques. 
T 
HE interaction of cells with the extracellular matrix is 
important for the formation, maintenance, and repair 
of tissues as well as for other biological processes such 
as the metastasis of cancer cells. This interaction is medi- 
ated, in part, by a family of cell surface receptors called inte- 
grins (Hynes, 1987; Ruoslahti and Pierschbacher, 1987; Buck 
and Horwitz, 1987). These receptors form a link between 
the extracellular matrix and the cytoskeleton a d may trans- 
mit signals from the extracellular to the intracellular envi- 
ronment hat affect cell behavior. 
Integrins are heterodimers comprised of a and/3 subunits, 
that are noncovalently associated transmembrane glycopro- 
teins. At least 11 0/chains (Ruostahti and Giancotti, 1989) 
and 6/3 chains (Sheppard et al., 1990) have been recognized 
in man. Each 0/subunit tends to associate with only one type 
of/3 subunit, but there are several exceptions to this rule 
(Hemler et al., 1989; Cheresh et al., 1989; Holzmann et al., 
1989; Freed et al., 1989). 
This is publication No. 6533-IMM from the Research Institute of Scripps 
Clinic. 
We and others have previously reported the identification 
of an integrin expressed primarily on epithelial-type cells, 
termed 0/E/34 or 0d6/34 (Kajiji et al., 1987, 1989; Hemler et 
al., 1989). The alpha subunit, 0/6, also appears to associate 
with the/3, integrin subunit and, on platelets, u6/3~ has been 
shown to function as a laminin receptor (Sonnenberg et al., 
1988). 
Here we report the complete cDNA sequence and the 
deduced amino acid sequence of both the 0/6 and the /34 
subunits. Both 0/6 and /34 are homologous with the other 
integrin 0/and/3 chains, respectively. However, they contain 
unique structural features which may suggest novel func- 
tional properties. 
Materials and Methods 
Cells 
The human pancreatic arcinoma cell line FG was cultured as described 
previously (Kajiji et al., 1989) in RPMI 1640 supplemented with 10% fetal 
calf serum, 2 mM glutamine, and penicillin-streptomycin (50 IU/ml-50 
#g/m/). The human colon carcinoma cell line LoVo (Drewinko et al., 1976) 
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was cultured in DME supplemented as above. Human platelets were the 
generous gift of Dr. Mark Ginsberg (Research Institute of Scripps Clinic, 
La JoUa, CA). 
Cell Labeling 
FG cells (107) were metabolically labeled with [35S]methionine as de- 
scribed previously (Kajiji et ai., 1989). Platelets were surface labeled with 
[125I]sodium iodide and lactoperoxidase essentially as described by Roth 
(1975). Preparation of nonionic detergent cell extracts, immunoprecipita- 
tion, and analysis by SDS-PAGE have been described previously (Kajiji et 
al., 1989). 
Antibodies 
The mouse monoclonal ntibody S3-41 and the rabbit polyclonal antibody 
5710 recognize 0/aft4 (Kajiji et al., 1987, 1989). The rat monoclonal nti- 
body GoH3 (Sonnenberg etal., 1987), which is specific for ctr, was the 
generous gift of Dr. Arnoud Sormenberg (University of Amsterdam, The 
Netherlands). The "anti-o/6 cyto" rabbit antiserum was raised to a synthetic 
pepride (IHAQPSDKERLTSDA) corresponding to the carboxy terminus of 
0/6 based on the deduced amino acid sequence reported here. The mono- 
clonal antibody, AA3, was produced using standard hybridoma procedures 
(Kohler and Milstein, 1975) from mice immunized with placental 0/6/34 
purified on $3-41 affinity columns (Kajiji et al., 1989). AA3 has been shown 
to be specific for the/34 subunit by immunoprecipitarion and Western blot- 
ring. Full characterization f this antibody will appear elsewhere (Cooper, 
H. M., and V. Quaranta, manuscript in preparation). 
cDNA Library Screening 
Three different cDNA libraries were constructed (Invitrogen, San Diego, 
CA) from mRNA isolated from FG cells: an oligo-dT primed expression 
library in Xgtll and two plasmid (pTZISR Bst XI; Invitrogen) libraries, one 
oligo-dT primed, and the other random primed. 
The following oligonucleotides were synthesized with a Gene Assembler 
(Pharmacia, Uppsala, Sweden) according to the amino-terminal sequence 
of the mature 0/6 protein (Kajiji et ai., 1989): (a) 40-mers with 64-fold 
redundancy covering the first 13 amino acids (FNLDTREDNVIRK) 
5'-TTCAAC T TAGACACGCGAGAGGACAACGTAATCCGAAAGT-3'. 
C G T T G G 
(b) 14-mers covering the complete redundancy of the first 5 amino acids 
(1) 5'-TTTAATCTAGATAC-Y 
C C T C 
(2) 5'-TTTAATCTGGATAC-Y 
C C C C 
(3) 5'-TTTAATTTGGACAC-Y. 
C C A T 
Screening of the random-primed DNA library was performed with the 40- 
mers, labeled with [3,32p]ATP and I"4 polynucleoride kinase (labeling kit 
from Pharmacia), using low stringency conditions (hybridization at 37°C 
overnight and washes with 2x SSC at room temperature and at 46°C, 30- 
min each). 44 positives were then hybridized with the complete set of 14- 
mers followed by washes in 3.0 M tetramethylammonium chloride (TMAC) 
at progressively higher temperatures a  described by Wood et ai., (1985). 
Three clones, 0/6.1, ct6.31, and ct6.44, remained positive up to the melting 
temperature of 14-mers (46°C). 
The insert from the 0/6.1 eDNA clone was isolated and used to screen 
the oligo-dT primed eDNA library. Preparation ofprobes, filters, hybridiza- 
tion, and washes were performed according to Maniatis et al. (1982). 
The ),gtll library ("-,1 × 106 plaques) was screened (Young and Davis, 
1983) with the rabbit antiserum 5710, which was raised against purified hu- 
man 0/6B4 and previously shown by Western blots to react predominantly 
with/34 (Kajiji et al., 1989). 72 positive clones from the antibody screen- 
ing were plaque purified and the eDNA inserts were amplified irectly from 
bacteriophage plaques using the polymerase chain reaction (PCR). l 
Briefly, a plug of agar containing the plaque was transferred to 1 ml of SM 
(10 mM Tris-HC1 pH 8.0, 50 mM NaC1, 5 mM MgC12) and incubated for 
either 1 h at room temperature or overnight at 40C. 10/zl of supernatant 
1. Abbreviations used in this paper: ORE open reading frame; PCR, poly- 
merase chain reaction. 
was used in a 50 #1 PCR containing 67 mM Tris-HCl pH 8.8, 1.5 mM 
MgCI2, 10 mM /3-mercaptoethanol, 1.25 U of TAQ I polymerase, 0.25 
mM each of dATE dTTE dCTE and dGTP, and 0.1 #g each of 24-mer oli- 
gonuclcotides corresponding to sequences of )~gtl 1 flanking the Eco RI 
cloning site. The PCR program consisted of 3 steps: (a) one cycle at 94°C 
for 4 min; (b) 40 cycles of I rain at 94"C, 2 min at 55°C, and 3 rain at 72"C 
with a 5-per cycle extension on the 72°C segment; (c) 10 rain at 72"C and 
a final shift to 4°C. These amplified fragments were isolated using G-ene 
Clean (Bio 101, La Jolla, CA), digested with either Eco RI or Not I, 
repurified with Gene Clean, and subcloned into pKS+ (Stratagene, La 
Jolla, CA). 
The 72 positive inserts were arranged into 11 groups based on cross- 
hybridization. Fusion proteins produced by clones representative of a group 
were used to select epitope specific antibodies (Weinberger et al., 1985) 
from the rabbit antiserum, 5710. These antibodies were tested for their abil- 
ity to immunoprecipitate/34 from a SDS/heat-denatured FG lysate. The 
clone lam 18.2.1 (part of a group of 13 crosshybridizers) was identified as 
a/~4 clone by this epitope selection method (Fig. 5 A). The insert from this 
clone was used to screen both of the plasmid cDNA libraries to isolate over- 
lapping clones. Additional screenings were done using radiolabeled inserts 
from/3,, positive DNA clones until the complete/34 eDNA was isolated. 
DNA Sequencing 
The 0/6 cDNA clones were sequenced from restriction fragments (Pvu II or 
Sma I for 0/6.1; Ava I + Barn HI or Eco RI + Hind HI for 0/6.1-7) subcloned 
into pKS+. The/34 cDNA clones were sequenced from nested eletion 
subclones created using a kit from Pharmacia. Both strands were sequenced 
by dideoxy chain termination (Sanger et al., 1977) either on an ABI 370A 
DNA Sequencer (Applied Biosystems, Inc. Foster City, CA) or manually 
(Sequenase kit; USB, Cleveland, Ohio) using either the T3 and T7 polymer- 
ase vector primer sequences orspecific oligonucleotide primers ynthesized 
to appropriate r gions of the t~ or/~4 sequence. Sequences were analyzed 
on a VAX-VMS version 5.2 computer, with the programs of the University 
of Wisconsin Genetics Computer Group (Devereux et ai., 1984). 
cDNA Synthesis and PCR 
Poly-A+ RNA was isolated from human placenta nd human carcinoma 
cells (Fast Track Kit; Invitrogen). 2-5 #g was used to synthesize cDNAs 
with AMV reverse transcriptase (20 U; Molecular Genetics Resources, 
Tampa, FL) and 1 #g of random hexamer primers (Pharmaeia). The cDNAs 
were extracted with phenol/chloroform, precipitated with ethanol, and 
resuspended in 100 #1 of water. 1 #1 was amplified using the PCR conditions 
described above xcept for the primer concentrations (1 #M each) and, for 
reactions using oligos 3 + 4 and oligos 5 + 6, the annealing temperature 
(52°C). The following oligonucleorides were used (see Fig. 6 for number- 
ing; 5' nucleotide is in bold face type): (a) (82-98), (b) (310-329), (c) 
(4441-4482), (d) (4679--4697), (e) (4679-4697), and (f) (4805-4820). 10 
#1 of the PCR mixture were separated on a 3.5% acrylamide gel along with 
1 kb molecular size markers (Bethesda Research Laboratories, Gaithers- 
burg, MD) and the DNA was visualized by staining with ethidium bromide. 
To confirm the identity of PCR bands, these were subcloned and se- 
quenced. Briefly one-haif of PCR reaction was purified on glass beads 
(Geneclean, Bio 101) and ligated in the Sma I site of the vector pKS+ 
(Stratagene). Plasmids prepared from bacteria transformed with the ligarion 
mixture were restriction digested and their inserts, if present, were se- 
quenced in both directions as described above. 
Immunof luorescence  
Cultured carcinoma cells were trypsinized, plated on coverslips coated with 
Matrigel (Collaborative Research, Lexington, MA) and cultured for 2 d. 
They were then fixed and stained with appropriate antibodies as described 
(Marehisio et al., 1984). Briefly, cells were fixed in 3% paraformaldehyde 
for 10 rain at room temperature, permeabilized with the nonionic detergent 
Triton X100 (0.5%) for 5 rain on ice, and then incubated with primary anti- 
bodies: mouse monoclonal AA3 specific for human /34, control mono- 
clonal Q5/13 specific for HLA-DR, a monoclonal antibody specific for 
vineulin (Sigma Chemical Co., St. Louis, MO), affinity-purified rabbit anti- 
bodies to talin (a gift from E Giancotti, La Jolla Cancer Research Foun- 
dation, La Jolla, CA), protein A-purified anti-o/6 cytoplasmic tail anti- 
bodies, control, irrelevant, rabbit immunoglobulin. Aetin was stained with 
fluorescein isothiocyanate-conjugated phalloidin (Sigma Chemical Co.). 
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Secondary  ant ibod ies  were aff inity pur i f ied goat  ant i - rabb i t  or  ant i -mouse  
immunog lobu l ins ,  con jugated  to e i ther  f luorescein or  rhodamine  (S igma 
Chemica l  Co.) .  Cel ls  were v iewed with a Ze iss  Ax iophot  mic roscope  
equ ipped with an  ep i f luorescence source,  and  photographed on Kodak  
T -max 3200.  
Results 
Isolation of cDNA Clones Encoding tr6 
We have previously isolated the integrin 0/6~4 from human 
carcinoma cells and human placenta and determined the 
amino-terminal sequence of both subunits (Kajiji et al., 
1989). Based on the sequence of the amino terminus for 0/6, 
degenerate oligonucleotides were synthesized and used to 
screen 3 × 105 colonies from a random primed human pan- 
creatic carcinoma (FG) cDNA library as described in 
Materials and Methods. Three clones with inserts of "~1.2 
kb were isolated and sequenced. All three clones (0/6.1, 
0/6.31, and 0/6.44) overlapped and contained open reading 
frames (ORFs) whose deduced amino acid sequence matched 
exactly the protein sequence of the amino terminus of 0/6 
(Kajiji et al., 1989; Hemler et al., 1989). 
To isolate the rest of the 0/6 gene, "~7.2 × 105 colonies of 
the oligo-dT primed cDNA plasmid library was screened 
with the radiolabeled insert from the 0/6.1 clone. Of 16 posi- 
tive clones, one (0/6.1-7) had an insert of 4.8 kb. Overlapping 
restriction endonuclease fragments of the 0/6 cDNA inserts 
were subcloned into pKS and sequenced in both orienta- 
tions. Fig. 1 A shows the overall relationship of the 0/6 
cDNA clones to one another and the restriction sites relevant 
for subcloning and sequencing. The resulting sequence con- 
sists of 146 bp of the 5'-untranslated region, an ORF of 3,219 
bp encoding 1,078 amino acids, and 2,264 bp of the 3'-un- 
translated region (Fig. 2). 
Analysis of the Primary Structure of a6 
Preceding the amino terminus of the mature protein is a pos- 
sible signal sequence of 23 amino acids. The mature protein 
is comprised of 1,055 amino acids with a Mr ,~117,000. The 
addition of carbohydrate with an average 2,500 Mr to the 
protein core at the 10 potential N-glycosylation sites (N-X- 
S/T) would result in an estimated size of 142,000 Mr. This 
relative molecular mass corresponds well with the 150,000 
Mr estimated from the migration of 0/6 on SDS-polyacryl- 
amide gels under nonreducing conditions. 
A hydropathy profile (Kyte and Doolittle, 1982) of the 
deduced protein sequence identified a putative transmem- 
brane region from amino acid residues 1,012-1,037. After 
this transmembrane r gion are 36 amino acids (residues 
1,038-1,073) which comprise the presumed cytoplasmic do- 
main. Analysis of the amino-terminal portion of the mole- 
cule revealed seven homologous repeat (domain I, residues 
42-79; II, 113-145; III, 185-217; IV, 256-292; V, 314-352; 
VI, 375-411; VII, 430-470). The last three domains each 
contain a sequence motif resembling the cation binding site 
consensus sequence of D-X-D/N-X-D/N-G-X-X-D found in 
a number of calcium-binding proteins (Van Eldik et al., 
1982). A fourth site, residues 230-238, with weak homology 
to this calcium binding site motif resides between repeated 
domains III and IV. These potential cation binding sites are 
in a region (residues 189-488) of the molecule that is devoid 
of cysteine residues. 
The migration of 0/6 in SDS-polyacrylamide g ls under 
reducing conditions indicated that 0/6 consisted of two poly- 
A 
0 1 2 3 4 5 6kb 
I I I I I I I 
A AAAA A A RRA AR A BH A 
~1. , , ,  . J  ,I , II I 
I I  I I 
SPS P 
o.6.1 
ot6.31 
ot6.44 
ot6.1-7 
RB R 
I I  I 
B. 0 1 2 3 4 5 6kb 
I I I I I I I 
l 
2.15.26 
01 
0 1 2 ~  
2.24.12A 
40.11.25.1 
23 II 
k18.2.1 ~ 
3O N/  
k30 N/  
Figure 1. Restriction map of the a6 (A) and ~4 
(B) cDNA clones. The ORFs for 0/6 and/3a re 
shown as open bars. The lines indicate the size 
and position of the plasmid and phage cDNA 
clones isolated from the three cDNA libraries. 
Restriction sites relevant to subcloning and se- 
quencing are Ava I (A), Bam HI (B), Pvu II 
(P), Eco RI (R), and Sma I (S). Representative 
clones out of a total of 54 are shown for/34. 
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1 C~GCC~CGT~C~GGGGGTGGGGC~GGGCGCAGCGGCC~GGAGGCGAAGGTGGCTGCGGTAGCAC~~C~~ 
I01 AGGC~CGCTC-CAGGTCCCCGCTCCCCT COCGTGCGTCCGCCCATGGCCGCCGCCGGGCAGCTGT GCTTGCTCTACCTGTCGGCGGGGCTCCTGTCC 
M A A A G Q L C(~L  L Y L S A G L L S 18 
201 CGGCTCGGCGCAGCCTTCAACTTGGACACT~C,C~GGACAA~GTGATC~GGAAATATGGAGA~CCGGGAGCCTCTTCGG~GCTGGCCATGCACT 
R L G A AA F N L D T R ~ D N V I R K Y G D P G S L F G F S L A M H W 52 
301 GGCAACTGCAGCCCGAGGACAAGCC~C~GTGGGGGCCCCGCGCC~AGAAGCGCTT~CACTGCAGAGAGCCTTCAGAAC~A~G 
Q L Q P E D K R L L L V G A P R G E A L P L Q R A F R T G G L Y S 85 
401 CTGCGACATCACCGCCCGGGGGCCATGCACGCGGATCGAGTTTGATAACGATGCTGACCCCACGTCAGAAAGCAAGC~GAT~T~CC 
Q D I T A R G P (~) T ~  R I E F D N D A D P T S E S K E D Q W M G V T 118 
501 GTCCAGAGCCAAGGTCCAGGGGGCAAGGTCGTGACATGTGCTCACCGATATGAAAAAAGGCAGCATGTTAATACGAAGCAGGAATCCCGAGACAT CTTTG 
V Q S Q G P G G K V V T (~ A H R Y E K R Q H V N T K Q E S R D I F G 152 
601 GGCGGTGTTATGTCCTGAGTCAGAATCTCAGGATTGAAGACGATATGGATC~GATTGGAG~-F~F1~GTC~TGGGCGATTGAGAGGCCATGAGAAA~ 
R ~)  Y V L S Q N L R I E D D M D G G D W S F ~ D G R L R G H E K F 185 
701 TGGCTCTTGCCAGCA~GTAGCAGCTA~TF~CTAAAGAcTTTCATTACATTGTATTTGGAG~CCCGGGTACTTATAACTGGAAAGGGATTGTTCGT 
Q Q G V A A T F T K D F H Y I V F G A P G T Y N W K G I V R 218 G S 
801 GTAGAGCAAAAGAATAACAc~-r~-FF~TC~CATGAACATCTTTGAAGATGGGCCTTATGAAGTTGGT~GAGACTGAC,CATGATGAAAGTCTCGTTCCTG 
F D M IN I F E D G P Y E l V G G E T E H D E S L V P V 252 V E Q K II N T F 
901 TTCCTGCTAACAGTTACTTAC~ITFFI~I'I~f C~CTCAGGGAAAGGTATTGTTT C AAAGATGAGATCACTTTTGTATCTGGTC~CCCAGAGOCAATCA 
P A N S Y L G F  S L D S G K G I  V S K D E  I T F V S G A P R A N H  285 
1001 CAGTGGAGCCGTGGTTTTGCTGAAGAGAGACATGAAGTCT CACATCTCCTCCCTGAGCACATATTCGATGGAGAAGGTCTGGCCTC~CATTTGGCTAT 
S G A V V L L K R D M K  S A H L L P  EH I F D G E G L A S S F G Y  318 
1101 GATGTGGCGGTGATGGACCTCAACAAGC~TGGGTGGCAAGA~ATAGTTATTGGAGCCCCACAGTA1~F~GA~AGAGATGGA~T~GT~ 
D V A V M I D  L NK D G W Q  DI I  V I G A P  QY F D RD G E V G G A V  Y 352 
1201 ATGTCTACAT GAACCAGCAAGGCAGATGGAATAATGTGAAGCCAATTCGTCTTAATGGAACCAAAGATTCTAT GTTTGGCATTGCAGTAAAAAATATTGG 
V Y M N Q Q G R W N N V K P I R L I~ G T K D S M F G I A V K N I G 385 
1301 AGATATTAATCAAGATGGCTAcCCAGATATTGCAGTTGGAGCTCCGTATGATGACTTGGC~G~F~-~ATCTATCATGGATCTGCAAATGGAATAAAT 
ID I N QD G Y P  D I I  AV  G A P  Y D D n G K V  F I Y H G S A N  G I N 418 
1401 ACCAAACCAACACAGGTTCTCAAGGGTATATCACCTTATTTTGC~TATTCAATTGCT G AAACATGGACCTTGATCGAAATT CCTACQCTGATGTTGCTG 
T K P T Q V L K G I S P Y F G Y S I A G N S ID L D R N S Y P D I V A V 452 
1501 TTGG'ITCCCTCTCAGATTCAGTAACTA~rTCAGATC CCGGCCTGTGATTAATA~TCAGAAAACCATCACAGTAACTCCTAACAC~'f GACCTCCGCCA 
G S L S D S V T I F R S R P V I N I Q K T I T V T P N R I D L R Q 485 
1601 GAAAACAGCGTGTGGGGCGCCTAGTGGC~TATGCCTCCAGGTTAAATCCTGT~TATACTGCTAACCCCGCTGGTTATAATCC~CAATATCAATT 
g T A ~ G  A P S G I (~L  Q v K S~)F  E Y T A N P A S Y N P S I S I 518 
1701 GTC~CACTTC,  AAGCTGAAAAAC, AA~GAAAATCTGGGCTATCCTCAAGAGTTCAG~CGAAACCAAGGTT CTGAGCCCAAATATACTCAAGAAC 
V G T L E A E K E R R K S G L S S R V Q F R N Q G S E P K Y T Q E L 552 
1801 TAACTCT C,AAGAGGCAGAAACAGAAAGTGTGCATGGAC~C~CTGTGGCTAC~TAATATCAGAGATAAACTGCGTCCCATTCCCATAACT GCCTC 
T L K R Q K Q K V (~ M E E T L W L Q D N I R D K L R P I P I T A S 585 
1901 AGTGG~GATCCAAGAGCCAAGCTCTCGTAGGCC~GTGAATTCACTTCCAGAAG~CCAATTCTGAA~T~CC~~TA~T 
V E I Q E P S S R R R V N S L P E V L P I L N S D E P K T A H I D 618 
2001 GTTCACTTCTTAAAAGAGGGATGTGGAGACGACAATGTATGTAACAGCAACCTTAAACTAGAATATAAATTTTGCACCCGAGAAGGAAATCAAGACAAAT 
2101 TTTCTrATTTACCAATTCAAAAAGGTGTACCAGAAcTAGTTCTAAAAGATCA~TAT.~GCTTTAGAAATAACAGTGACAAACAGCCCTTCCAACCC 
S Y L P I Q K G V P E L V L K D Q K D I A L E I T V T N S P S N P 685 
2201 AAGGAATCCCACAAAAGATGG~TGACGCC CATGAGGCTAAACTGATTGCAACGTTTC CAGACACTTTAACCTATTCTGCATATAGAGAACTGA~ 
R N P T K D G D D A H E A K L I A T F P D T L T Y S A Y R E L R A 718 
2301 TTCCCT GAGAAACAG2"f GAGTTGTGTTGCCAACCAGAATGC~CC~GCT GACTGTGAGCTC GCgkAATCL 'F I~ I " I 'AAAAGAAA~TGT~ 
F P E K e L S ~ V A  N Q N G S O A D~)E  L O N P F K R N S NV T F Y 752 
2401 ATTTC~dI-FF1"AAGTACAACT GAAGTCACC~CACCOCATATCTGGATATTAATCTGAAGTTAGAAACAACAAGCAATCAAGATAA~'rTGGCTCCAAT 
L V L S T T E V T F D T P Y L D I N L K L E T T S N Q D N L A P I 785 
2501 TACAGCTAAAGCA~ATTGAACTGL-FFF I  AT OGGTCTCGGGAGTTGCTAAACCTTCCCAGGTGTATTTTGGAGGTACAGTTGTTGGOGA~ 
T A K A K V V I E L L L S V S G V A K P S Q v y F G G T V V G E Q 818 
2601 GCTATGAAATCTGAAC~TC'AAGTGGGAA~AATAGAGTATGAATTCAGGGTAATAAACTTAGGTAAACCTCTTACAAACCTCGGCACAGCAACCTTGA 
A M K S E D E V G S L I E Y E F R V I N L G K P L T N L G T A T L N 852 
2701 ACATTCAGTGGC~GAAATTAGCAATGGGAAATGGTTGCTTTATTTGGTGAAAGTAGAATcCAAAGGATTGC~GGTAACTTGTGAGCCACAAAA 
I Q W P K E I S N G K W L L Y L V K V E S K G L E K V T ~ E P Q K 885 
2901 GCTGAAAGAAAATACCAGACTC~AAcTGTAC4DGTGAACGTGAACTGTGTGAACATCAGATGCCCGCTC~GGGGG~CAGCAA~ ~ ~  
3001 TGCC-cTCGAGGTTATGGAACAGCACAT~CTAGAGGAATATTCCAAACTGAACTACTTGGACATTCTCATC42GAGCCTTCATTGATGTGACTGCTGCT ~ 
R S R L W II S T F L E E Y S K L N Y L D I L M R A F 1 D V T A A A 985 
3101 CGAAAATATCAC~TGCAGGCACTCAGGTT CGAGTGACTGTGTTTCCCTCAAAGACTGTAGCTCAGTATTCGGGAGTACC~GGTGC~TCAT C 
E N I R L P N A G T Q V R V T V F P S K T V A Q Y S G V P W W I I 1018 
3201 CTAGTGGCTA~TcTC~TCTTGATC~ATTAG5~-TTTATACTATGGAAGTGTGGTTTCTTCAAGAGAAATAAGAAAC~TCATTATGATG 
3301 CCACATATCACAAGGCTGAGATCCATC42TC~TCTC~TAAAGAGAGC42'~ACTTcTGAT~ATAGTATTC~TCTACTTCTGTAA'~.TGTGTGGA~ 
T Y H K A E I H A Q P S D K E R L T S D A 1073 
3401 TTAAACGCTCTAGGTACGATGACAGTG~CCCCGATACCATGCTGTAAGGATCCGGAAAGAAGAG~GAGAGATCAAAGATGAAAAGTATATTGATAAC C  
3501 TGAAAAAAAACAGTGGATCACAAAGTGGAACAGAAATGAAAGCTACTCATAC~GGGGGCCT GCTTCACAGTACCCAAACTC~cF~-rITC 
3601 CAACTCAGAAATTCAATTTGGATTTAAAAGCCTGCTCAAT CCCTGAGGACT GATqTCAGAGTGACTACACACAGTACGAACCTACAG~~ 
3701 TATTGTTACGTAGCCTAAGGCTCC~F~TIGCACAGCC~TTTAAAACTGTTGGAATGGA ~'F~-I-IL'TTTAACTGCOGTAATTTAAC~CTGGGTTGCC 
3801 TTTt~-FFFF~.GGCGTC~C~ACATCATGTGTTGGGGAAGGGCCTGCCCAGTTGCACTCAGGTC~CATCCTCCAC~TAGT~A~~C~ 
3901 ACACTCACCTGCACTAACAGAGT GCCGT CCTAACCTCGGGCCTC~GCGCAGACGTCCATCACGTTAGCTGTCCCACATCACAAGACTATGC~ ~ 
4001 GTAGTTGTGT~CAACGGAAAGTGCTGTCTTAAACTAAATGTGCAATAGAAGGTGATGTTGC CA C TACCGTCTTTTCCTG~CCTAGCT G'TGTGAAT 
4101 ACCTGCTCACGTCAAAT GCATACAAGT~CATTCTCCC~CACTAAAAACACACAGGTGCAACAC~CTTGAATGCTAGTTATACTTATTTGTATATGGT 
4201 ATTTAT~T~-~CTTTTCTTTACAAA~CATTTTGTTATTGACTAACAGGCCAAAGAGTCTCCAGTTTACCCTTCAGG~GGTTTAATCAATCAGAATTAGA 
4301 ATTAGAGCATGGGAGGGTCATCACTATC~CCTAAATTATTTACTGCA~GAAAATCTTTATAAATGTACCAGAGAGAGTTGTTTTAATAACTTATCTA 
4401 TAAACTATAACCTCTCCTTCATGACAC~CACCCCACAACCCAAAAGGTTTAAGAAATAGAATTATAACTGTAAAGATGTTTATTTCAGGCATTGGAT 
4501 A~-I-~-~TI'ACTTTAGA~GCATAATGTTTCTGGATTTACATACTGTAACATT CAGGAA~CTTGGAGAAC~TGGGTTTATTCACT C~ACTCTAGTGCG 
4601 GTTTACTCACTGCTGCAAATACTGTATATTCAGGACTTC•AAAC•AAATGGTGAATGCCTATGGAACTAGTGGATCCAAACTGATCCAGTATAAGACTACT G 
4701 AATCTGCTACCAAAACAGTTAATCAGTC~GTCGAGTGTTCTA~-~F~F~.G~G~CCT~CCCTATCTGTATTCCCAAAAA~f CT~GC~AATTT 
4801 AACA~AACTTTAAA~TGT~TFi~l~ATTGTAAAAATGGCAGGGGGTGGAATTATTACTCTATACATTCAACAGAGACTGAATAGATATGAAAGCT ATTT 
4901 "ITX-I-X /~ATTA(~CATGCTTCACAATGTTAAGTTATATGGGGAGCAACAGCAAACAGGTGCTAATTTt~-~.~fGGATATAGTATAAGCAGTGTCTGTGTTTTG 
5001 AAAGAATAGAACACAGTTTGTJ~'TGCCACTGTS~-I-F~-? GGG~"FF~'I-I-*-I'CTTTTTCCGGAAAATCC~AAACCTTAAC~TACTAAGGACGTT GTT 
5101 TTC~ACTTC~TTCTTAGTCACAAAATATATTTTGTTTACAAAAATTTCTGTAAAACAGGTTATAACAGT GTTTAAAGTCTCAGTTTCTTGCTTG 
5201 GGGAACTTGTGTCCCTAATGTGTTAGA~GCTAGATTGCTAAC-C~GCTGATACTTGACAG~n-I'FI~GACCTGT GTTACTAAAAAAAAGATGAATGTCGG 
5301 AAAAGGGTGTT~GGGTGGTCAACAAAGAAACAAAGATGTTATGGTG~AGACTTATGGTTGTTAAAAATGT CATCTCAAGTCAAGTCACTGGTCT G 
5401 TTTC~TTTGATACA2~FFF~GTACTAACTAGCATTGTAAAATTATTTCATGATTAGAAATTACCTGTGGATATTTGTATAAAAGTGT~ 
5501 TATAAAAGTGTTCATTGTTTCGTAACACAGCATTGTATATGTGAAGCAAACTCTAAAATTATAAATGACAACCTGAATTATCTATTTCATCAAAAAAAAA 
5601 AA~CTTTAT GGGCACAACT GG 
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peptides joined by a disulfide bridge (Sonnenberg et al., 
1987; Kajiji et al., 1989) similar to the integrin 0/subunits 
0/5, o/v, 0/,tB, and 0/Ps2. In the region of a6 corresponding to
this potential cleavage site (residues 899-923), there are 
three sets of dibasic residues. The use of two of these sites 
could account for the appearance of the smaller polypeptide 
as a doublet on SDS-polyacrylamide gels (Sonnenberg etal., 
1987). This doublet may also arise from differences in 
glycosylation atthe two sites present in the light chain. The 
sequence RKKRE, which most closely resembles the cleav- 
age site of other integrin 0/chains, is at position 899-903. 
Cleavage at this site would result in the formation of a heavy 
chain of 118,000 Mr and a light chain of 24,000 Mr, which 
are close to the 125,000 Mr and 30,000 Mr estimated by 
SDS-PAGE. 
Comparison of or6 with the Other Integrin oe Subunits 
Alignment with the other integrin 0/subunits hows that 0/6 
shares several structural features with these proteins (Fig. 
3). Of the 20 cysteines in the mature or6 protein, 11 are in 
equivalent positions to those found in the other 10 t~ chains, 
5 are shared with 9 of the other 10 alphas, and 2 are shared 
with the other 5 0/chains which do not contain the I domain. 
One cysteine (residue 1039) is shared with the PS2 0/chain, 
and another cysteine (residue 643) is unique to 0/6. Cys- 
teine 643 is in a region of the molecule (residues 641-689) 
in which two gaps of about 15 and 9 amino acids were placed 
in the other 0/ chains in order to optimize the alignment. 
Three of the four putative cation binding sites of 0/6 align 
with similar sites in the other 0/subunits. A fourth weakly 
homologous cation binding site (residues 230-238) pre- 
cedes, slightly, the cation binding sites present in the other 
c~ chains which lack the I domain. The cytoplasmic domain 
of 0/6 contains the sequence GFFKR which is absolutely 
conserved inall but the Drosophila PS2 0/subunit, where the 
K is replaced by an N. 
Some of the integrin 0/chains contain additional polypep- 
tide sequence. 0/2 and the 0/chains associated with 32 (O/L, 
O/M, 0/p,so) contain an insert domain (I domain) near the amino 
terminus of these molecules and the Drosophila PS2 0/sub- 
unit contains an insert just preceding the transmembrane por- 
tion of this molecule. 0/6 does not contain either of these in- 
serts. 
Based on the alignment shown in Fig. 3, o/6 shares 
18-26% identity with the other integrin alpha subunits. The 
highest homology is with o/v, 0/5, and 0/Ps2 (25-26% iden- 
tity) and the lowest homology is with those 0/chains which 
contain the I-domain (18% identity). 
Further Evidence for the Identity of the so cDNA 
Clones and Association of ~6 with Both/34 and/3i 
A rabbit antiserum (anti-o/6 cyto) was prepared to a syn- 
thetic peptide corresponding to the last 15 amino acids of the 
deduced a6 amino acid sequence. This antiserum precipi- 
tated the 0/6/34 complex from a radiolabeled FG lysate (Fig. 
4 A), indicating that the cDNA clones isolated in this study 
encode the 0/6 protein. We then tested this antiserum with 
platelets that express 0/6~1 (Sonnenberg etal., 1987) but not 
oe634. Fig. 4 B shows that this antiserum precipitated the 
0/6/3~ complex from a radiolabeled platelet lysate. These 
results provide further evidence that 0/6 forms stable hetero- 
dimers with both B~ and 34 (Hemler et al., 1989). However, 
they do not exclude the possibility of slight structural varia- 
tions in 0/6 which may be responsible for preferential s- 
sociation with either of the 3 chains. 
Isolation of cDNA Clones Encoding ~4 
The cDNA for/34 was isolated by antibody screening of a 
phage xpression library followed by colony hybridization of
two plasmid libraries (see Materials and Methods) (Fig. 5 
A). Overlapping clones covering •5.9 kb were sequenced 
(Fig. 1 B) and shown to encode /34 protein because: (a) 
they contain an ORF of 1,822 amino acids starting with a 27- 
residue putative signal peptide followed by a 13 amino acid 
sequence identical to the B4 protein amino terminus we pre- 
viously determined (Kajiji et al., 1989); (b) their nucleotide 
sequence is essentially identical to that of recently reported 
~4 cDNA clones from normal epithelial cells (Suzuki and 
Naitoh, 1990; Hogervorst et al., 1990), with the exception 
of two locations described in detail below. To summarize the 
salient features, the mature ~4 protein contains a 710 amino 
acid extracellular domain, showing obvious sequence ho- 
mology to integrin/3 chains (including cysteine conservation 
at 47/56 positions), followed by a predicted 23 amino acid 
transmembrane region, and finally 1,089 amino acids that 
presumably represent an unusually large cytoplasmic do- 
main. The total mass of the mature protein is 200,000 or 
212,500 if all five extracytoplasmic putative N-glycosylation 
sites are used. 
To test whether or not the large carboxyl-terminal se- 
quence was part of the ~4 protein in complex with 0/6, a na- 
tive FG lysate was immunoprecipitated with the antibodies 
eluted from the cytoplasmic domain fusion protein (clone 
lam-I 8.2. I). These antibodies precipitated a complex of pro- 
teins with SDS-PAGE mobilities identical to those of authen- 
tic 0/d3, heterodimers (Fig. 5 B). 
Evidence for Possible Multiple Forms of 3, mRNAs 
Some of the cDNA clones were found to contain insertions 
in two locations: one insertion was identified in the 5'-un- 
translated region, and the other in the coding region corre- 
sponding to the cytoplasmic tail. 
Thirteen independent clones, covering the 5' end of the/34 
cDNA, were sequenced. Six of them had an insertion of 49 
Figure 2. Nucleotide sequence and deduced amino acid sequence of the human c~6 subunit. The sequence corresponding with the amino- 
terminal sequence determined on a6 protein (Kajiji et al., 1989) is underlined. The putative transmembrane region is shown by a dashed 
underline. The arrowhead marks the position of cleavage between the signal sequence and the mature protein. Cysteines are circled. Poten- 
tial sites of N-linked glycosylation are shown in bold face. Closed boxes outline the putative cation binding domains. Dashed boxes outline 
dibasic residues that may represent sites of cleavage in the formation of a heavy and a light chain. The cytoplasmic sequence GFFKR, 
which is conserved in virtually all of the integrins o~ chains, is denoted by a stippled ashed box. A potential polyadenylation signal is 
boxed. These sequence data are available from EMBL/GenBank/DDBJ under accession umber X53586, 
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Figure 4. Immunoprecipitation f a~4 and 
ct6B~ with anti-o/6 cyto, an antibody raised to a 
synthetic peptide corresponding to the carboxy 
terminus of u6. (A) Autoradiogram of im- 
munoprecipitations of a detergent lysate of 
[~sS]methionine-labeled FG cells analyzed by 
SDS-PAGE under educing (R) or nonreducing 
(N) conditions. Antibodies used were: anti-o/6 
cyto (lanes 1), antiserum 5710 (lanes 2), and 
the monoclonal antibody $3-41 (lanes 3), both 
to 0/6/~4. (B) Autoradiogram of a SDS-PAGE 
analysis of immunoprecipitations of 1251 sur- 
face-labeled platelets with the monoclonal an- 
tibody to ~6, GoH3 (lanes 1), and the antise- 
rum anti-o/6 cyto (lanes 2). 
bp in the 5' untranslated sequence after position 129, 9 bp 
upstream of the ATG initiation codon (Fig. 6). 
The second insertion sequence was found in the cytoplas- 
mic tail where, in one out of the five clones analyzed, there 
was an insertion of 70 amino acids precisely in frame be- 
tween threonine 1369 and glutamic acid 1440, located after 
bp 4294 (Fig. 6). 
These extra sequences raised th  possibility that multiple 
forms of ~4 cDNA exist in carcinoma cells. In addition, a 
f14 cDNA from normal epithelial cells recently reported 
(Hogervorst et al., 1990) contains a 159-bp sequence in the 
cytoplasmic region not present in any of our clones and lo- 
cated after base pair 4,744 (Fig. 6, arrowhead). 
To determine whether these sequences were actually pres- 
ent in cellular mRNAs, we amplified mRNAs from various 
cells using PCR. Oligonucleotide primers flanking the sites 
of insertion were synthesized (in one case, see Fig. 7 A, an 
internal primer was used) as described in Materials and 
Methods. PCRs using the primers flanking the 5' region in- 
sert generated products, consistent with the two types of 
cDNA we found, i.e., with or without he 49-bp insert (248 
and 200 bp, respectively; Fig. 7 B, lanes 1 and 2), in two 
carcinoma cell lines tested (FG and LoVo). Of these, only the 
200-bp band (i.e., without the insert) was obtained from 
placental mRNA (Fig. 7 B, lane 3). Unexpectedly, one band 
of 260 bp was seen in placental amplification products, sug- 
gesting the possibility of additional insertions in this region. 
The low intensity of the bands obtained from placental 
cDNA for the amplification of this region may be explained 
by low representation f 5' mRNA sequences due to degrada- 
tion during mRNA extraction from tissues. 
To confirm their identity, these PCR bands were subcloned 
and sequenced. From FG and LoVo PCRs, clones corre- 
sponding to the 200- and 248-bp bands were found and 
shown to contain the correct nucleotide sequences. How- 
ever, clones for the 260-bp band, as well as clones from 
placenta PCRs were not obtained. The identity of these 
bands deserves further study. 
Using oligonucleotide primers pecific to the region con- 
taining the insert at 4,294 bp (Fig. 7 B, lanes 4-6), a band 
of 255-bp was amplified from both LoVo and FG cDNAs but 
not from placenta cDNA, suggesting that mRNA containing 
this insert is expressed in carcinoma but not in normal ceils. 
PCR amplifications with primers flanking the insert at 
base pair 4,744 (Fig. 7 B, lanes 7-9) suggested that mRNAs, 
both with and without his insert, are present in placental tis- 
sue and that the form containing the insert is prevalent. In- 
stead, LoVo and FG carcinoma cell mRNA produce only 
PCR bands corresponding to the insert-minus form. The 
identity of the 144-, 255-, and 354-bp bands was confirmed 
by the sequences of subclones from the respective PCRs. 
These results suggest hat multiple alternatively spliced 
forms of f14 may exist in normal as well as transformed epi- 
thelial cells. 
Cellular Distribution of te~ 
The long cytoplasmic tail of ~/4 is suggestive of unique in- 
teractions with cytoskeletal components. To gain some infor- 
mation on this possibility, the cellular distribution of c¢6~4 
with respect to adhesion plaques was examined by im- 
munofluorescence studies. FG carcinoma cells were plated 
on Matrigel-coated glass, fixed, permeabilized, and stained 
by specific antibodies after 2 d of culture. The majority of 
the cells in these cultures had a typical epithelial appearance, 
forming clusters of 3-20 cells with epithelioid geometry, as 
Figure 3. Alignment of 0/6 deduced amino acid sequence with the other integrin 0/subunits. The other 0/chains are from human sources 
except where noted: 5 = fibronectin receptor (Argraves et al., 1987; Fitzgerald et al., 1987), V -- vitronectin receptor (Suzuki et al., 
1987), liB = gplIB (Poncz et al., 1987), 4 = VLA-4 (Takada et al., 1989), 2 = VLA-2 (Takada and Hemler, 1987), P150 (Corbi et 
al., 1987), M = MacI (Arnaout et al., 1988; Corbi et al., 1988), L = LFAI (Larson et al., 1989); M(M) = murine MacI (Pytela, 1988), 
and the position specific (PS2) c~ chain from Drosophila (Bogaert et al., 1987). Initial alignment was generously provided by Dr. Robert 
Pytela and modified to include the 0/6 sequence with the aid of sequence comparison programs (Devereux et al., 1984). Closed circles 
and open circles represent positions were a residue is conserved among all 11 0/chains or in 10 of 11 chains, respectively. Inverted u'iangles 
denote residues found in all six (c osed) or five or six (open) of the 0/subunits which do not contain the I-domain. Potential cation binding 
sites are boxed with a closed line and a highly conserved cytoplasmic sequence (GFFKR) is boxed with a dashed line. 
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Figure 5. Immunoprecipitation of/34 with anti- 
bodies selected with the lam 18.2.1 fusion pro- 
tein. (A) Antibodies eluted from plaques lam 
23.1.1 (lanes 1), lam 8B (lanes 2), and lam 
18.2.1 (lanes 3) were used for immunoprecipi- 
tations of a denatured [35S]methionine FG ly- 
sate and analyzed by SDS-PAGE under reduc- 
ing (R) or nonreducing (N) conditions. (B) ~4 
specific monoclonal antibody, AA3 (lanes 1) 
and antibodies eluted from plaque lain 18.2.1 
(lanes 2) were used for immunoprecipitations 
of a nondenatured [35S]methionine FG lysate 
and analyzed by SDS-PAGE. 
evidenced by phase-contrast microscopy (Fig. 8, 1 A, 2 A, and 
3 A). That these cells form adhesion plaques was shown by 
staining with antibodies to vinculin and talin, which can be 
visualized as spots on the external edges of spread cells in 
the periphery of the clusters (Fig. 8, 1 B and 3 B). Actin, 
specifically stained by fluorescent phalloidin, was also ob- 
served on the outer edges of spread cells in a pattern of 
spikes, and on the inside of these cells in small patches (Fig. 
8, 2 B). However, no clearly recognizable actin stress fibers 
were seen. 
In cells stained simultaneously for both talin and/34, the 
talin staining on the outer edges was often juxtaposed to that 
of/34 (Fig. 8, 3 B and 3 C, arrows) but was not overlapping. 
In parts of the basal surface interior to the edge of the cells, 
talin was not detectable, while/34 was visible and appeared 
to be arranged in small patches and streaks (Fig. 8, 3 C, ar- 
rows). Cells double-stained with both anti-vinculin (mouse 
monoclonal) and anti-a6 cytoplasmic tail (rabbit antibod- 
ies) gave very similar patterns to thecells double stained for 
talin and/34 (not shown). These results suggest that the cel- 
lular distribution of a~4 is distinct from that of adhesion 
plaques. 
Discuss ion 
We have isolated cDNA clones encoding both a and /3 
subunits of the epithelial integrin, ct6/34. The ct subunit was 
sequenced from two overlapping clones encoding a protein 
of 1,073 amino acids. Identification of these clones as c~6 
came from two pieces of evidence. First, the ORF contained 
a sequence that matched exactly the sequence of the amino 
terminus of the mature ct6 protein (Kajiji et al., 1989). Sec- 
ond, an antiserum to a synthetic peptide corresponding to 
the putative ~6 carboxy terminus in the ORF recognized the 
O~6/34 complex in immunoprecipitations f radiolabeled car- 
cinoma cell lysates. 
Structurally, a6 is very similar to the other integrin ct 
subunits that have been cloned to date. It shares 23-26% 
identity with those subunits which do not contain the I do- 
main insert (cts, av, ~r~, c~4, and Ctps2) and '~18% identity 
with those c~ chains that do contain it (a~, C~L, aP150, and c~2) 
(see alignment shown in Fig. 3). 
All of the integrin a proteins contain three potential cation 
binding sites. A fourth potential site exists in four of the c~ 
chains which do not contain the I domain. In contrast, (~6 
lacks this fourth cation binding site which makes it, along 
with a4, an exception to the the classification of integrin tx 
subunits proposed by Takada and Hemler (1989). There is 
a site (residues 230-238) with weak homology to the cation 
binding site consensus sequence. However, this site does not 
align with a potential site in any of the other tx chains. It starts 
with an asparagine instead of an aspartic acid residue, and 
it contains a phenylalanine where an aspartic acid or 
asparagine r sidue is expected. These differences are, for the 
moment, of unclear significance, and await elucidation from 
x-ray crystallographic data. 
Similar or identical forms of c~6 have been reported to as- 
sociate with either of two integrin /3 subunits, /3, or /34 
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1 GC~CGT~CCCA~CCCCAAC~C~CGCGCCCGCCCTCGGACAGT~CCTGCTCGC~CC~GCAGC~CCATCTCCTAGCC~GCCCAGG~GcGAGTCC 
121 GCCCCGAG~AGGTCCAGGACGGGCC.CACACK~GCAGCCGAGGCTGGC~GC~KG~C~AGGAAGAGGATGGCAGGGCCA~GCCCCAG~TC~ . GOCTTGAT 
M A G P R P S P W A R L L L A A L I 18 
241 CAGCGTCA C~C~GCTC~C*~KGGCCCCAGTGAAGAGCTC-CACGGAGTGTGTCCGTGTGGATAAGGACTG~GCCTACTGCACAGACGAGATGTTCAGGGA 
S V S L S G T L A I~ I~ .C ~ I~ A ~ %[ K S C T ~ C V R V D K D C A Y C T D E M F R D 58 .............. ::::::. :.: : ,r.: ........... 
361 CCGGCC-CTGCAACACCCAGGCGC~GCTGGCCGCC~CAGCC~C~GCATCGTC43TCATGGAGAGCAGCTTCCAAATCACAGA~C~~C~ ..... 
R R C N T Q A E L L A A G C Q R E S I V V M E S S F Q I T E E T Q I D T T L ...... 96 
2288 
4085 
4201 
4321 
4441 
4561 
4681 
4801 
....... CACAAGAAGAAC~CTGCCCTCC~GGCTCAT~CCCTGCTCCTCCTCCTC~CCTGGCCcTGCTACTGCTGCTATGCTGG~ACTGT ..... 
...... H K K K D C P P G S F W W L I P L L L L L L P L L A L L L L L C W K Y C ...... 736 
i i 
.... ~ . GGGGGCCTGAGCGGGAGGCCATCATCAAOCTGGCCACCCAGC TGTCCATCOCCATCATCCCTGACATCCCTATCGTGGACGCCCA 
... A R N G A G W G P E R E A I I N L A T Q P K R P M S I P I I P D I P I V D A Q 
GAGC~ACGACAGCT' IYX3TLKTGTACAGC,  GATGACGTTCTACC, ~ C T C C A ~ C ,  CGTCT CCC*%TGACAC ~ ~ 
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Gc' rGc-GGG~ .GCTCA Ct~,CG~GC-COCCCACC~CCCCCCC~AC 
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G A C G G C G G C G C ~ ~ ~ C G C A G T G C G A C A C ~ C C G G ~ G ~ T G C 4 2 C G G A T G G A  GCACCAACTCCCT 
T A A R A G R A A A V P R S A T P G P P G ~ H L V N G R M D F A F P G S T N S L 
GCACAC-GATGACCACF.4~CCA~CTATGGCACCCA~~ AAGCACA CA~CTACAACTCACTGA~ 
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5525 .... ACCCTC~CAGCACCTCKI%Cd3CAC~CCTCACCCC~TGTGAOCCAC-C~GCOC~CACrGACCACCAC~A~~C~ 
• . T L G A Q H L E A G G S L T R H V T Q E F V S R T L T T S G T L S T H M D Q Q 1818 
5641 GTTCTTOCAAACTTGA~CCC~GCCCCACCCCCC~CATGTCCCACTAGGCGTCCTCC GCCTCCTCAGCTACTCCATCCTTGCA GOCC 
F F Q T * 1822 
5761 ACCCC-CATGCACAGAGC~AGGTGTCTCCT~GGCATGAAGGGGGCAAGGTCC CCTATTTGTAACCAAAGA CAAGGACCCAG 
5881 (DCTTr GITCT C41~CTTAATAAATGt =~FFi"t C -CTA~ 
Figure 6. Nucleotide sequence and deduced amino acid sequence of the human ~4 subunit, highlighting the regions where insertions oc- 
cur, presumably based on alternative mRNA splicing. The beginning and end of the sequence as well as the position of the predicted trans- 
membrane s gment (dark bar underline) are shown for orientation. The region containing the amino-terminal sequence determined on 
~4 protein (Kajiji et al., 1989) is underlined with a lightly shaded bar. Alternate splice regions are boxed. The arrowhead at base pair 
4,744 shows the site of insertion of 159-bp stretch reported by Hogervorst et al. (1990)• The complete sequence data (5, 918 bp) are available 
from EMBL/GenBank/DDBJ under accession umber X53587. 
(Hemler et al., 1989). We present further evidence of this 
alternative association. Antiserum raised to a synthetic pep- 
tide corresponding to the carboxy terminus of 0/6 reacts 
with both O/6~ 4 from pancreatic arcinoma cells and 0/6~1 
from human platelets. This reinforces the evidence, which 
includes identical amino-terminal sequences (Kajiji et al., 
1989; Hemler et al., 1989) and the sharing of monoclonal 
antibody epitopes and peptide maps (Hemler et al., 1989), 
for a close structural similarity between the 0/6 molecules 
associated with either ~4 or ~1, However, these results do 
not exclude the possibility that small structural differences, 
perhaps due to alternative exon splicing or posttranslational 
modifications, may be responsible for the differential associ- 
ation with either ~4 or/3,. Alternatively, if such differences 
do not exist, the relative affinities of ~4 and/3, for a6 may 
regulate their association. 
In cells that express both ~, and/34, OL6 appears to form 
heterodimers preferentially with ~4 as observed by our- 
selves (DeLuca et al., 1990) and others (Hemler et al., 1989; 
Kennel et al., 1989). Regions unique to 0/6 may be relevant 
for this preferential association. In this regard, two short 
regions of the 0/6 molecule (554-561 and 641-690) are not 
present in the other 0/subunits (Fig. 3). Further experiments 
are needed to examine the possibility that they may be in- 
volved in the formation of heterodimers with ~4, possibly 
by creating a higher affinity for ~, than/3,. 
The primary structure of the integrin subunit/34 showed 
some unusual features. Homology to other integrin/3 chains 
ends at the border of the extracytoplasmic region and the 
predicted transmembrane region. After this point, the /34 
sequence is completely divergent, with the exception of two 
conserved residues (WK) positioned at the end of the trans- 
membrane region, which may, therefore, be essential for 
structure or function. While ~1, /32, and/33 have cytoplas- 
mic tails of the same length (47 amino acids), with many 
identifies or conserved substitutions, these sequences are en- 
firely absent from/34. Instead, B4 contains a surprisingly large 
cytoplasmic domain comprised of >1,000 residues. The pre- 
diction of a long cytoplasmic tail for ~4 confirms recent 
reports from two other laboratories which isolated similar 
cDNAs from normal epithelial cells (Suzuki and Naitoh, 
1990; Hogervorst et al., 1990). 
In addition, we provide direct evidence that the putative 
cytoplasmic domain deduced from these cDNA clones is, in 
fact, part of the f14 protein (Fig. 5). Antibodies eluted from 
a fusion protein containing the carboxy terminus of the ORF 
of these cDNAs immunoprecipitated the 0/6~4 complex 
from nondenatured lysates, and a ~4-1ike protein from cell 
lysates in which the interaction of 0/6 with/34 was disrupted 
by denaturation. Since the 205,000-Mr form of ~4 can be 
accounted for entirely by the size of the polypeptide back- 
bone and the addition of N-linked carbohydrates, our previ- 
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Figure 7. PCR products from carcinoma and 
placental cDNA primed with oligonucleo- 
tides for potential alternative splice sites. 
(A) Diagrams illustrating the location and 
expected size of PCR products. Solid lines 
represent the regions of the cDNAs being 
amplified. The boxes with vertical lines rep- 
resent the potential inserts observed in this 
study, and the box with diagonal lines repre- 
sents the potential insert in the/34 sequence 
reported by Hogervorst et al. (1990). Num- 
bers to the left of each line are the size of 
the expected PCR product. Numbers above 
each line are the nucleotide positions just 
preceding the insert based on the number- 
ing scheme shown in Fig. 6. Position and 
orientation of primers is indicated by the ar- 
rowheads. Oligonucleotides ar  described 
in Materials and Methods: 1 + 2 were used 
for insert 129, 3 + 4 were used for insert 
4,294, and 5 + 6 were used for insert 4,744. 
(B) PCR products from FG cDNA (lanes 1, 
4, and 7), LoVo cDNA (lanes 2, 5, and 8), 
and placental cDNA (lanes 3, 6, and 9) were 
analyzed on a polyacrylamide gel as de- 
scribed in Materials and Methods. 
ous suggestion that the three different forms of/3, (Mr = 
205,000, 180,000, and 150,000, Kajiji et al., 1989) may be 
due to large amounts of sialic acid appears to be incorrect. 
Proteolytic leavage may be a more accurate xplanation for 
the heterogeneity in the molecular mass of/34 as suggested 
by others (Hemler et al., 1989). 
The/34 sequences we obtained from carcinoma cells con- 
tain a few differences compared to the/34 cDNAs isolated 
from normal epithelial cells (Hogervorst et al., 1990; Suzuki 
and Naitoh, 1990). A 49-bp insertion located 9-bp upstream 
of the ATG translational start site was found in 6 of 13 
cDNAs we sequenced. It is possible that this region may be 
of regulatory importance (e.g., for translation efficiency). 
Furthermore, we found clones encoding two versions of the 
cytoplasmic tail of ~4. One of these is identical to that 
reported by Suzuki and Naitoh (1990). The other contains 
an insertion of 70 amino acids after threonine 1,369. Both 
of our sequences are different from that reported by Hoger- 
vorst et al. (1990), which contains an i sertion of 53 amino 
acids after histidine 1,519. Thus, it appears that the/34 cyto- 
plasmic domain can exist in at least three versions. 
A likely explanation for some or all of these insertions is 
alternative exon splicing of primary mRNA transcripts. Such 
mechanisms have been described in many other mRNAs 
(Smith et al., 1989), including the integrin subunits/33 (Van 
Kuppevelt et al., 1989) and PS2 c~ (Brown et al., 1989). Con- 
sistent with the possibility of alternative splicing, we de- 
tected PCR amplification products of the expected size using 
primers located either within or adjacent o the insertions. 
That mature cytoplasmic mRNA, rather than immature nu- 
clear transcripts, acted as templates in these PCR reactions 
is suggested by the fact that independent poly-(A) + RNA 
preparations yielded identical results, and that the relative 
ratio of the various forms remained constant within, and was 
characteristic of, a given cell type. For instance, the 4,744 
insert was detectable in placenta but not in carcinoma cells, 
while the 4,294 insert had the opposite pattern (Fig. 7 B). 
Further experiments are, however, necessary to conclusively 
identify the origin of the multiple forms of the /34 mRNA 
and to gain insight into their functional significance. In par- 
ticular, it is necessary to verify the existence of distinct pro- 
tein forms corresponding to the three versions of the/34 cy- 
toplasmic domain. 
The unique cytoplasmic domain of/34 suggests intracellu- 
lar interactions distinct from those of other integrins. When 
engaged with extracellular matrix ligands, several types of 
integrins participate in the formation of structures called 
adhesion plaques (or focal adhesions) characterized by the 
colocalization of integrin receptors with the adhesion plaque 
components vinculin and talin, and with the ends of actin 
stress fibers (Buck and Horwitz, 1987). By immunostaining, 
we have shown here that the ~6/34 integrin is localized at the 
basal surface of adhering carcinoma cells (i.e., in areas of 
the plasma membrane contacting substrate). However, the 
distribution of c~6/34 is distinct from that of talin, suggesting 
that c~d~4 may not participate in adhesion plaque formation 
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Figure 8. Immunofluorescence staining of FG carcinoma cells. The cells were cultured on Matrigel-coated glass coverslips for 2 d, and 
then fixed and detergent permeabilized. (1 A) Phase contrast; (1 B) anti-vinculin antibodies. (2 A) Phase contrast; (2 B) phalloidin (actin- 
binding). (3 A) Phase contrast; (3 B) anti-talin antibodies; (3 C) simultaneous taining with anti-/34 antibodies. The plane of focus was 
kept at the basal surface of the cells. In 3 B and 3 C areas of interest are indicated as follows: (a) wavy arrows, areas internal to the edges 
stained by anti-/34 antibodies but not anti-talin antibodies; (b) straight arrows, areas on the edges of peripheral, spread cells where talin 
and/34 staining are juxtaposed but not overlapping; (c) arrowheads, areas where talin and/34 staining were observed by careful focussing 
to be distinct. See text for further explanations. Bar, 10 #m. 
in adhering carcinoma cells. It is possible that an inappropri- 
ate substrate was used in our experiments, as the ligand of 
0/6/$4 is not biochemically identified. However, we have 
made similar observations on cultured keratinocytes that can 
be detached by anti-/$4 antiserum (DeLuca et al., 1990). 
Together with the unusual /34 cytoplasmic tail, these data 
suggest hat the biology of 0/6/34 may differ substantially 
from other well-characterized integrins. 
In conclusion, while the role of 0/6/$4 in epithelial cell 
adhesion remains to be established, the availability of 0/6 
and/$4 cDNAs should now facilitate this task. 
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Note Added in Proof The sequence of c¢3 from hamster was recently pub- 
lished (Tsuji, T., F. Yamamoto, Y. Miura, K. Takio, K. Tatani, S. Pawar, 
T. Osawa, and S. Hakomori. 1990. J. Biol. Chem. 265:7016-7021). 
Alignment with the t~6 amino acid sequence resulted in 37% identity, 
significantly higher than all other integrin ot chains. 
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